Hospital
Ahmc Garfield Medical Center LP
Ahmc Garfield Medical Center LP was paid $17.83M by Medicaid between Jan 2018 and Nov 2024, across 177 billing codes. Its largest line is 0450, Emergency room services — 39% of everything it billed.
33Billing provider infoAHMC GARFIELD MEDICAL CENTER LP
MONTEREY PARK, CA 91754
MONTEREY PARK, CA 91754
33aNPI1730171265assigned 08/19/2005
33bProvider typeGeneral Acute Care Hospital
28Total paid$17.83M
24GClaims439,999
24DCodes billed177
24AFirst – last monthJan 2018 – Nov 2024
Compared with peers
Next to other General Acute Care Hospital providers in California
Rank by total paid#131 of 410
Median peer was paid$6.90M
This provider vs. median2.6×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Auditor's notes
Automated statistical signals. Not evidence of fraud — how these are computed.
Entity ProliferationAuthorized official MARSH, LINDA controls 11+ related entities in our dataset. Read more
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 78,669 | $3.07M | |
| 2019 | 69,652 | $3.27M | |
| 2020 | 50,800 | $1.91M | |
| 2021 | 51,042 | $2.06M | |
| 2022 | 58,162 | $2.55M | |
| 2023 | 66,807 | $2.76M | |
| 2024incomplete | 64,867 | $2.22M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 0450 | Emergency room services | 39% | 39,482 | 36,780 | $6.94M |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 23% | 8,205 | 7,803 | $4.05M |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | 2.9% | 2,057 | 2,031 | $516K |
| 0270 | 2.9% | 38,678 | 24,871 | $512K | |
| 70450 | Computed tomography, head or brain; without contrast material | 2.0% | 2,047 | 2,001 | $351K |
| J3490 | Unclassified drugs | 1.8% | 34,528 | 17,157 | $325K |
| 0360 | 1.8% | 2,979 | 2,070 | $320K | |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | 1.3% | 3,778 | 3,439 | $235K |
| 80053 | Comprehensive metabolic panel | 1.3% | 20,822 | 19,588 | $226K |
| 99199 | Unlisted special service, procedure or report | 1.1% | 4,431 | 4,013 | $191K |
| 93458 | 1.0% | 194 | 188 | $187K | |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 1.0% | 6,537 | 6,299 | $184K |
165 more codes
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 12,826 | $176K |
| S3620 | Newborn metabolic screening panel, includes test kit, postage and the laboratory tests specified by the state for inclusion in this panel (e.g., galactose; hemoglobin, electrophoresis; hydroxyprogesterone, 17-d; phenylalanine (pku); and thyroxine, total) | <1% | 1,125 | $166K |
| 99285 | Emergency room visit (most serious) | <1% | 492 | $158K |
| 0710 | <1% | 3,711 | $158K | |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | <1% | 5,144 | $152K |
| Z7502 | <1% | 3,832 | $136K | |
| 71045 | Radiologic examination, chest; single view | <1% | 12,725 | $126K |
| 0250 | <1% | 6,946 | $115K | |
| C9803 | Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | <1% | 4,822 | $111K |
| 99283 | Emergency room visit (moderate) | <1% | 1,347 | $110K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 23,207 | $106K |
| 76815 | Ultrasound, pregnant uterus, real time with image documentation, limited | <1% | 1,535 | $103K |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 4,485 | $91K |
| 0160 | <1% | 557 | $89K | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 6,186 | $87K |
| 81001 | <1% | 14,788 | $85K | |
| 97139 | <1% | 4,106 | $72K | |
| J2704 | Injection, propofol, 10 mg | <1% | 1,228 | $69K |
| 84484 | <1% | 8,867 | $67K | |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | <1% | 5,756 | $60K |
| 85730 | <1% | 8,725 | $60K | |
| Z7610 | <1% | 4,236 | $60K | |
| 87811 | Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) | <1% | 2,581 | $58K |
| G0378 | Hospital observation service, per hour | <1% | 149 | $51K |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | <1% | 1,746 | $50K |
| J7030 | Infusion, normal saline solution , 1000 cc | <1% | 8,548 | $48K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 1,395 | $45K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | <1% | 1,159 | $41K |
| 85610 | <1% | 8,829 | $40K | |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed | <1% | 1,020 | $40K |
| 0272 | <1% | 4,367 | $39K | |
| 76705 | Ultrasound, abdominal, real time with image documentation; limited | <1% | 1,303 | $39K |
| 96361 | Intravenous infusion, hydration; each additional hour | <1% | 3,091 | $35K |
| 81025 | <1% | 6,898 | $32K | |
| 83880 | <1% | 3,144 | $31K | |
| A4217 | Sterile water/saline, 500 ml | <1% | 3,897 | $31K |
| 83690 | <1% | 6,726 | $30K | |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 3,521 | $30K |
| 0762 | <1% | 262 | $28K | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 4,738 | $27K |
| 97799 | <1% | 1,903 | $26K | |
| Z9725 | <1% | 599 | $26K | |
| J7120 | Ringers lactate infusion, up to 1000 cc | <1% | 1,861 | $25K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 2,958 | $25K |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 4,810 | $23K |
| 80306 | <1% | 1,663 | $23K | |
| 45380 | Colonoscopy, flexible; with biopsy, single or multiple | <1% | 246 | $23K |
| J0131 | Injection, acetaminophen, not otherwise specified,10 mg | <1% | 260 | $23K |
| 76856 | Ultrasound, pelvic (nonobstetric), real time with image documentation; complete | <1% | 660 | $22K |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 2,548 | $22K |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 3,446 | $20K |
| 97163 | <1% | 306 | $20K | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 1,719 | $18K |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | <1% | 639 | $18K |
| 76700 | Ultrasound, abdominal, real time with image documentation; complete | <1% | 246 | $17K |
| 87040 | <1% | 1,496 | $17K | |
| J0690 | Injection, cefazolin sodium, 500 mg | <1% | 1,434 | $17K |
| 78454 | <1% | 239 | $17K | |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | <1% | 65 | $16K |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | <1% | 1,026 | $16K |
| 90715 | <1% | 697 | $15K | |
| 71046 | Radiologic examination, chest; 2 views | <1% | 976 | $14K |
| 86900 | <1% | 1,967 | $12K | |
| 82550 | <1% | 2,345 | $12K | |
| J2270 | Injection, morphine sulfate, up to 10 mg | <1% | 2,869 | $12K |
| 0459 | <1% | 154 | $11K | |
| 84702 | <1% | 1,311 | $11K | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 904 | $10K |
| 97161 | <1% | 296 | $9K | |
| A4649 | Surgical supply; miscellaneous | <1% | 1,745 | $9K |
| 74018 | <1% | 599 | $9K | |
| J3010 | Injection, fentanyl citrate, 0.1 mg | <1% | 3,083 | $9K |
| 83605 | <1% | 1,606 | $9K | |
| 86901 | <1% | 2,010 | $9K | |
| 83735 | <1% | 2,464 | $8K | |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | <1% | 2,355 | $8K |
| 76805 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation | <1% | 158 | $8K |
| 45378 | Colonoscopy, flexible; diagnostic, including collection of specimen(s) | <1% | 104 | $8K |
| 93971 | <1% | 126 | $8K | |
| 86886 | <1% | 1,205 | $7K | |
| 85027 | <1% | 1,850 | $7K | |
| 82948 | <1% | 2,319 | $7K | |
| 43239 | Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple | <1% | 122 | $7K |
| 73564 | <1% | 218 | $5K | |
| 85007 | <1% | 1,762 | $5K | |
| J7042 | 5% dextrose/normal saline (500 ml = 1 unit) | <1% | 530 | $5K |
| A9502 | Technetium tc-99m tetrofosmin, diagnostic, per study dose | <1% | 138 | $4K |
| 73630 | <1% | 299 | $4K | |
| 73610 | <1% | 235 | $4K | |
| 73130 | <1% | 226 | $4K | |
| 73030 | <1% | 252 | $4K | |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 129 | $4K |
| 87070 | <1% | 247 | $4K | |
| 82150 | <1% | 788 | $4K | |
| 0750 | <1% | 13 | $4K | |
| 84703 | <1% | 1,033 | $3K | |
| J1644 | Injection, heparin sodium, per 1000 units | <1% | 286 | $3K |
| 36415 | Collection of venous blood by venipuncture | <1% | 1,327 | $3K |
| 87186 | <1% | 346 | $3K | |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | <1% | 127 | $3K |
| 83520 | <1% | 329 | $3K | |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | <1% | 838 | $3K |
| 0300 | <1% | 122 | $3K | |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 416 | $3K |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 672 | $2K |
| 80061 | Lipid panel | <1% | 674 | $2K |
| J7050 | Infusion, normal saline solution, 250 cc | <1% | 513 | $2K |
| 93017 | <1% | 154 | $2K | |
| 87420 | <1% | 295 | $2K | |
| 94664 | <1% | 288 | $2K | |
| 88313 | <1% | 71 | $2K | |
| 99070 | <1% | 348 | $2K | |
| J0780 | Injection, prochlorperazine, up to 10 mg | <1% | 294 | $1K |
| J7121 | 5% dextrose in lactated ringers infusion, up to 1000 cc | <1% | 190 | $1K |
| 81002 | <1% | 988 | $1K | |
| 76817 | Ultrasound, pregnant uterus, real time with image documentation, transvaginal | <1% | 48 | $1K |
| 88312 | <1% | 46 | $939.45 | |
| 99221 | <1% | 54 | $928.69 | |
| J2785 | Injection, regadenoson, 0.1 mg | <1% | 95 | $806.76 |
| J2765 | Injection, metoclopramide hcl, up to 10 mg | <1% | 237 | $782.38 |
| 88304 | <1% | 134 | $756.10 | |
| 85379 | <1% | 159 | $750.92 | |
| J0330 | Injection, succinylcholine chloride, up to 20 mg | <1% | 50 | $704.18 |
| J2060 | Injection, lorazepam, 2 mg | <1% | 177 | $685.29 |
| J0153 | Injection, adenosine, 1 mg (not to be used to report any adenosine phosphate compounds) | <1% | 28 | $646.68 |
| 71010 | <1% | 50 | $640.27 | |
| 87430 | <1% | 98 | $627.07 | |
| J7040 | Infusion, normal saline solution, sterile (500 ml = 1 unit) | <1% | 298 | $616.38 |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | <1% | 38 | $574.01 |
| 99152 | <1% | 24 | $559.80 | |
| 73110 | <1% | 41 | $474.24 | |
| 76830 | Ultrasound, transvaginal | <1% | 26 | $460.75 |
| 72100 | <1% | 15 | $458.45 | |
| 0320 | <1% | 91 | $432.53 | |
| 97140 | Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) | <1% | 98 | $413.36 |
| 97165 | <1% | 30 | $382.72 | |
| S0164 | Injection, pantoprazole sodium, 40 mg | <1% | 79 | $332.14 |
| 86920 | <1% | 29 | $311.75 | |
| 87081 | <1% | 86 | $276.47 | |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | <1% | 29 | $235.86 |
| 99153 | Mod sedat endo service >5yrs | <1% | 32 | $232.03 |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | <1% | 14 | $204.35 |
| 96366 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour | <1% | 15 | $200.15 |
| J3370 | Injection, vancomycin hcl, 500 mg | <1% | 31 | $186.33 |
| 84145 | <1% | 28 | $162.60 | |
| 86140 | <1% | 30 | $154.96 | |
| S0077 | Injection, clindamycin phosphate, 300 mg | <1% | 13 | $148.75 |
| 0636 | <1% | 44 | $140.85 | |
| 12001 | <1% | 13 | $109.03 | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 52 | $99.94 |
| J1170 | Injection, hydromorphone, up to 4 mg | <1% | 47 | $86.72 |
| 82553 | <1% | 22 | $83.89 | |
| 94150 | <1% | 12 | $83.50 | |
| 73140 | <1% | 12 | $59.04 | |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | <1% | 13 | $57.36 |
| J2470 | Injection, pantoprazole sodium, 40 mg | <1% | 30 | $53.15 |
| 94200 | <1% | 12 | $30.70 | |
| 94729 | <1% | 12 | $27.80 | |
| 94726 | <1% | 12 | $23.10 | |
| 85651 | <1% | 30 | $21.68 | |
| 94760 | <1% | 12 | $14.43 | |
| 99072 | 0% | 106 | $0.00 | |
| 29799 | 0% | 12 | $0.00 | |
| S9445 | Patient education, not otherwise classified, non-physician provider, individual, per session | 0% | 28 | $0.00 |
| 43264 | 0% | 12 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialMARSH, LINDA (SENIOR VICE-PRESIDENT)
| Provider | Location | Paid |
|---|---|---|
| Ahmc Whittier Hospital Medical | Whittier, CA | $15.12M |
| Ahmc Anaheim Regional Medical | Anaheim, CA | $14.21M |
| Ahmc Monterey Park Hospital LP | Monterey Park, CA | $10.85M |
| Ahmc Greater El Monte Community | South El Monte, CA | $9.17M |
| Ahmc San Gabriel Valley Medical | San Gabriel, CA | $6.96M |
| Alhambra Hospital Medical Center, LP | Alhambra, CA | $6.90M |
| Ahmc Seton Medical Center LLC | Daly City, CA | $5.21M |
| Alhambra Hospital Medical Center, LP | Alhambra, CA | $1.57M |
| Ahmc San Gabriel Valley Medical | San Gabriel, CA | $249K |
| Alhambra Hospital Medical Center, LP | Alhambra, CA | $176K |
| Alhambra Hospital Medical Center, LP | Alhambra, CA | $34K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.